17 insiders reported 65 Form 4 transactions for Opus Genetics, Inc. (IRD) over the past 18 months (most recent 2026-05-20). Recent activity: Foundation Fighting Blindness Retinal Degeneration Fund (Director) Sell 1.7M shares, Foundation Fighting Blindness, Inc. (Director) Sell 1.7M shares, Zaremba Rabourn Amy (Head of Fin. Quality Assurance) Sell 1,641 shares, SCHACHLE JOSEPH K (Chief Operating Officer) Sell 4,697 shares, Gagnon Robert E. (Chief Financial Officer) Sell 7,842 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 1.7M | $7.4M |
| 2026-05-20 | Foundation Fighting Blindness, Inc. | Director | Sell | 1.7M | $7.4M |
| 2026-04-27 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | 1,641 | $8,540 |
| 2026-04-27 | SCHACHLE JOSEPH K | Chief Operating Officer | Sell | 4,697 | $24,519 |
| 2026-04-27 | Gagnon Robert E. | Chief Financial Officer | Sell | 7,842 | $40,658 |
| 2026-04-27 | YERXA BENJAMIN R | President | Sell | 7,470 | $39,121 |
| 2026-04-27 | Magrath George | Chief Executive Officer | Sell | 9,511 | $49,647 |
| 2026-04-27 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 7,542 | $39,156 |
| 2026-04-22 | MANUSO JAMES S J | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Rodgers Richard J | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Graves Adrienne L | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Benton Susan | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Ainsworth Sean | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Bennett Jean | Director | Buy | 24,367 | $0 |
| 2026-04-22 | Gallagher Cam | Director | Buy | 24,367 | $0 |
| 2026-03-18 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 3,719 | $19,041 |
| 2026-03-18 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | 2,816 | $14,784 |
| 2026-03-18 | SCHACHLE JOSEPH K | Chief Operating Officer | Sell | 3,719 | $19,525 |
| 2026-03-18 | Magrath George | Chief Executive Officer | Sell | 24,438 | $127,322 |
| 2026-02-17 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 5,313 | $18,011 |
| 2026-01-26 | SCHACHLE JOSEPH K | Chief Operating Officer | Buy | 250,000 | $0 |
| 2026-01-26 | Magrath George | Chief Executive Officer | Buy | 483,639 | $0 |
| 2026-01-26 | Gagnon Robert E. | Chief Financial Officer | Buy | 400,000 | $0 |
| 2026-01-26 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Buy | 86,500 | $0 |
| 2026-01-26 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Buy | 400,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-20